EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oral Butyrate Reduces Progression of Kidney Damage in an L‐ NAME ‐Induced Diabetic Kidney Disease Mouse Model

Maria Novella Nicese iD, Angela Koudijs, Reshma Lalai, Cristina Avramut, Rico J E Derks, Elena Sánchez-López, Martin Giera, Amanda C M Pronk, Artemiy Kovynev, Sander Kooijman, Patrick C N Rensen, Roel Bijkerk und 2 weitere

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Maria Novella Nicese und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Kidney, Butyrates. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rembrandt Institute of Cardiovascular Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Diabetic kidney disease (DKD) is one of the main causes of kidney failure worldwide. Interestingly, patients affected by DKD are characterised by a low abundance of gut bacteria producing short fatty acids including butyrate, which is suggested to play a role in the decline of renal function. Consequently, we aimed to test the effects of oral butyrate supplementation on kidney health in mice affected by DKD. Material and Methods To this end, we treated diabetic BKS db/db mice (C57BLKS/J Lepr db ) via drinking water with the eNOS inhibitor N(ω)‐nitro‐L‐arginine methyl ester (L‐NAME), which accelerates the progression of DKD. Simultaneously, mice were fed low‐fat chow with or without 5% butyrate.

Results

Oral butyrate supplementation reduced mesangial expansion, glomerular enlargement and medullary fibrosis in kidney biopsies of the mice. These protective effects correlated with an increased abundance of Akkermansiaceae in the gut. In mice treated with butyrate, the abundance of Akkermansiaceae positively correlated with glomerular filtration rate (GFR) and plasma concentration of indole‐3‐methyl acetate and indole‐3‐acetaldehyde, key metabolites associated with many beneficial cardiovascular effects.

Conclusions

In conclusion, oral butyrate supplementation in mice with DKD improves kidney morphology, accompanied by an increased abundance of Akkermansiaceae in the gut. Future studies, such as transplantation of Akkermansia , should reveal whether this relationship is causal and translate into improved kidney function in DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesKidneyButyratesAnimalsMiceDisease ProgressionAdministration, OralDisease Models, AnimalNG-Nitroarginine Methyl EsterMaleMice, Inbred C57BLGlomerular Filtration RateGastrointestinal Microbiome

Stichwörter der Autor:innen

cardiovascular diseasediabetic nephropathydietary interventiontype 2 diabetes

Substanzen

NG-Nitroarginine Methyl EsterButyrates

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
  • Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.

ORCID-Profile: Maria Novella Nicese

Förderung

  • Rembrandt Institute of Cardiovascular Science

Zitieren

APA

Nicese, M. N., Koudijs, A., Lalai, R., Avramut, C., Derks, R. J. E., Sánchez-López, E., Giera, M., Pronk, A. C. M., Kovynev, A., Kooijman, S., Rensen, P. C. N., Bijkerk, R., van den Berg, B. M., & Rotmans, J. I. (2026). Oral Butyrate Reduces Progression of Kidney Damage in an L‐ NAME ‐Induced Diabetic Kidney Disease Mouse Model. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71245

Vancouver

Nicese MN, Koudijs A, Lalai R, Avramut C, Derks RJE, Sánchez-López E, et al. Oral Butyrate Reduces Progression of Kidney Damage in an L‐ NAME ‐Induced Diabetic Kidney Disease Mouse Model. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71245

BibTeX
@article{Nicese2026,
  author = {Nicese, Maria Novella and Koudijs, Angela and Lalai, Reshma and Avramut, Cristina and Derks, Rico J E and Sánchez-López, Elena and Giera, Martin and Pronk, Amanda C M and Kovynev, Artemiy and Kooijman, Sander and Rensen, Patrick C N and Bijkerk, Roel and van den Berg, Bernard M and Rotmans, Joris I},
  title = {Oral Butyrate Reduces Progression of Kidney Damage in an L‐ NAME ‐Induced Diabetic Kidney Disease Mouse Model},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71245}
}
Kostenlos starten →